$12 million grant funds foundational research on early liver transplantation
Alcohol-associated liver disease accounts for 50% of liver-related deaths, and its rates are rising worldwide. But one of the best treatment options, early liver transplantation (ELT)—transplants done with no mandatory period of abstinence from alcohol—is also one of the most controversial, partly because of concerns that patients will relapse to alcohol after transplantation.
Part of the problem is that livers for transplants are in short supply, and researchers lack data to determine who will benefit most from ELT. Studies show that decisions about who gets a transplant can, at times, be influenced by bias or unsystematic. ...








